New York Prioritizes “Non-White” As High Risk–Eligible to Receive Covid Treatment First

Objectivity 4.5 | Credibility 4.8 | Relevance 4.8

New York’s Department of Health released a document detailing its plan to distribute monoclonal antibody treatment and antiviral pills to treat Covid. The plan includes a section on high-risk factors that people must meet to receive the treatment, with one of those factors being “non-white” because “longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from Covid-19.” Citizens have called out the leadership of New York for discriminating based on ethnicity and skin color.

Click here to read New York state, Department of Health memo that claim social inequities have contributed to increased risk.